Pulse Biosciences (PLSE) Gross Profit (2021 - 2026)

Pulse Biosciences (PLSE) posted quarterly Gross Profit of -$193000.0 for Q3 2025, up 85.05% quarter-over-quarter from -$1.3 million in Q4 2022.

Pulse Biosciences (PLSE) Gross Profit (2021 - 2026) Analysis & Trends

Pulse Biosciences' Gross Profit history runs 3 years deep, the most recent figure standing at -$193000.0 for Q3 2025.

In Q3 2025, Gross Profit changed N/A year-over-year to -$193000.0; the TTM figure through Sep 2025 stood at -$193000.0 (changed N/A YoY), while the FY2022 annual figure was -$11.2 million, down 1879.58% from the prior year.
Gross Profit for Q3 2025 stood at -$193000.0, up from -$1.3 million in the prior quarter.
The five-year high for Gross Profit was -$153000.0 in Q3 2021, with the low at -$8.4 million in Q3 2022.
The 3-year median for Gross Profit is -$465000.0 (2022), against an average of -$1.7 million.
Peak annual rise in Gross Profit reached 211.08% in 2022, while the deepest fall reached 5390.2% in 2022.
Pulse Biosciences' Gross Profit stood at -$415000.0 in 2021, then slumped by 211.08% to -$1.3 million in 2022, then jumped by 85.05% to -$193000.0 in 2025.
Business Quant data shows PLSE's Gross Profit at -$193000.0 in Q3 2025, -$1.3 million in Q4 2022, and -$8.4 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn
10	Pulse Biosciences	3.50 Bn	3.50 Bn	161,000.00

Download Data